Clinical Trial Update: THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining the use of THAL-DEX (thalidomide-dexamethasone) in a double peripheral blood stem cell autotransplantation approach for untreat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Decadron (Dexamethasone)
• Thalomid (thalidomide)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED